The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.
Although generally effective, various antiepileptic drugs have been reported on occasion to increase seizure frequency, result in seizure relapse, or elicit new types of seizures. Some seizure types and epilepsy syndromes appear more prone than others to exacerbation by a given drug. Vigabatrin is rarely associated with seizure worsening, and then mainly in patients with resistant generalized epilepsies.
Lortie
A
A
Département de Neuropediatrie, Hôpital Saint-Vincent de Paul, Paris, France.
Chiron
C
C
Mumford
J
J
Dulac
O
O
D000614:Aminocaproates / Q000009:adverse effects* / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D012008:Recurrence; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D020888:Vigabatrin